Literature DB >> 8624841

Activation of protein phosphatase-1 isoforms and glycogen synthase kinase-3 beta in muscle from mdx mice.

E Villa-Moruzzi1, F Puntoni, O Marin.   

Abstract

Three Protein Phosphatase-1 (PP1) isoforms (PP1 alpha, PP1 gamma-1 and PP1 delta) are found in skeletal muscle. These are bound to regulatory subunits, such as inhibitor 2 (I2) in the cytosol and G in the glycogen and microsomal fractions. In vitro, the PP1-12 complex is activated by Glycogen Synthase Kinase-3 (GSK-3 or FA). We investigated the activities and protein levels of the three PP1 isoforms and of GSK-3 in muscle of mdx dystrophic mice. PP1 was assayed as phosphorylase phosphatase, in the presence of 5 nM okadaic acid (which inhibits PP2A). Peptide antibodies were produced and used to investigate PP1 alpha, PP1 gamma-1 and PP1 delta. GSK-3 was assayed using a previously described peptide. This was synthesized in a pre-phosphorylated from, which avoids the additional use of Casein Kinase II. Higher PP1 activity was assayed in the cytosol from mdx rather than from control muscles. Immunoprecipitation indicated that only PP1 alpha and PP1 gamma-1 were more active. This was most likely due to enzyme activation, since the immunodetected proteins were unchanged. On the other hand, the immunodetected PP1 delta was lower in the glycogen and microsomal fractions from mdx muscle. GSK-3 was more active in the mdx extract Selective immunoprecipitation of GSK-3 alpha and GSK-3 beta indicated that both isoforms were activated. In the case of GSK-3 beta, the immunodetected protein was also increased. The changes described herein may be related to the pathological events occurring in the mdx muscle. These include increased protein degradation and turnover, and fibre regeneration. In fact, the decreased PP1 delta may be due to protein degradation and the increased GSK-3 may be the consequence of increased protein turnover or regeneration. The apparent correlation between the increased PP1 alpha and PP1 gamma-1 activities and the increased GSK-3 may agree with the hypothesis that GSK-3 activates the newly synthesized PP1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624841     DOI: 10.1016/1357-2725(95)00119-0

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  9 in total

1.  Localization of myosin phosphatase target subunit and its mutants.

Authors:  Yue Wu; Andrea Murányi; Ferenc Erdodi; David J Hartshorne
Journal:  J Muscle Res Cell Motil       Date:  2005-07-01       Impact factor: 2.698

2.  Phosphorylation of protein phosphatase-1 isoforms by cdc2-cyclin B in vitro.

Authors:  F Puntoni; E Villa-Moruzzi
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

3.  Regulation of FAK Ser-722 phosphorylation and kinase activity by GSK3 and PP1 during cell spreading and migration.

Authors:  Mariarita Bianchi; Stefania De Lucchini; Oriano Marin; David L Turner; Steven K Hanks; Emma Villa-Moruzzi
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

4.  Cell-cycle-dependent association of protein phosphatase 1 and focal adhesion kinase.

Authors:  M Fresu; M Bianchi; J T Parsons; E Villa-Moruzzi
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

5.  Differential localization of myosin and myosin phosphatase subunits in smooth muscle cells and migrating fibroblasts.

Authors:  K Murata; K Hirano; E Villa-Moruzzi; D J Hartshorne; D L Brautigan
Journal:  Mol Biol Cell       Date:  1997-04       Impact factor: 4.138

6.  Differential subcellular localization of protein phosphatase-1 alpha, gamma1, and delta isoforms during both interphase and mitosis in mammalian cells.

Authors:  P R Andreassen; F B Lacroix; E Villa-Moruzzi; R L Margolis
Journal:  J Cell Biol       Date:  1998-06-01       Impact factor: 10.539

7.  GSK3 inhibition with low dose lithium supplementation augments murine muscle fatigue resistance and specific force production.

Authors:  Kennedy C Whitley; Sophie I Hamstra; Ryan W Baranowski; Colton J F Watson; Rebecca E K MacPherson; Adam J MacNeil; Brian D Roy; Rene Vandenboom; Val A Fajardo
Journal:  Physiol Rep       Date:  2020-07

8.  A Low-Therapeutic Dose of Lithium Inhibits GSK3 and Enhances Myoblast Fusion in C2C12 Cells.

Authors:  Nigel Kurgan; Kennedy C Whitley; Lucas A Maddalena; Fereshteh Moradi; Joshua Stoikos; Sophie I Hamstra; Elizabeth A Rubie; Megha Kumar; Brian D Roy; James R Woodgett; Jeffrey A Stuart; Val A Fajardo
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

Review 9.  The PKA-p38MAPK-NFAT5-Organic Osmolytes Pathway in Duchenne Muscular Dystrophy: From Essential Player in Osmotic Homeostasis, Inflammation and Skeletal Muscle Regeneration to Therapeutic Target.

Authors:  Sandrine Herbelet; Caroline Merckx; Boel De Paepe
Journal:  Biomedicines       Date:  2021-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.